Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Leases (2019 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Current Leases for 7 consecutive years, with $21.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 18.34% year-over-year to $21.3 million, compared with a TTM value of $21.3 million through Sep 2025, up 18.34%, and an annual FY2024 reading of $18.2 million, up 6.73% over the prior year.
  • Current Leases was $21.3 million for Q3 2025 at Tandem Diabetes Care, up from $19.9 million in the prior quarter.
  • Across five years, Current Leases topped out at $21.3 million in Q3 2025 and bottomed at $8.1 million in Q1 2022.
  • Average Current Leases over 5 years is $14.8 million, with a median of $17.1 million recorded in 2023.
  • The sharpest move saw Current Leases dropped 14.46% in 2022, then surged 96.15% in 2023.
  • Year by year, Current Leases stood at $9.3 million in 2021, then surged by 41.41% to $13.1 million in 2022, then skyrocketed by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then increased by 17.21% to $21.3 million in 2025.
  • Business Quant data shows Current Leases for TNDM at $21.3 million in Q3 2025, $19.9 million in Q2 2025, and $20.7 million in Q1 2025.